CORC

在结果中检索

CORC

浏览/检索结果: 共475条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Calibration of Agent-Based Model Using Reinforcement Learning 会议论文
Beijing, 2021
作者:  Song B(宋冰);  Xiong G(熊刚);  Yu S（于松民）;  Ye P（叶佩军）;  Dong X（董西松）
收藏  |  浏览/下载：0/0  |  提交时间：2023/06/26
Consideration and Design of HEPS Beam Instrumentation 会议论文
Brazil, 2020
作者:  J.H. Yue;  J.S. Cao;  Y.Y. Du;  J. He;  F. Liu
收藏  |  浏览/下载：35/0  |  提交时间：2021/05/25
Contextual Stroke Classification in Online Handwritten Documents with Graph Attention Networks 会议论文
澳大利亚,悉尼, 2019-9
作者:  Jun-Yu Ye;  Yan-Ming Zhang;  Qing Yang;  Cheng-Lin Liu
收藏  |  浏览/下载：12/0  |  提交时间：2021/03/30
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：44/0  |  提交时间：2019/12/05
The Modified Subtype Classification for Gastric Neuroendocrine Neoplasms 会议论文
作者:  Li, Yuanliang;  Zhang, Pan;  Zhang, Yu;  Li, Xiaokou;  Zhou, Zhiwei
收藏  |  浏览/下载：42/0  |  提交时间：2019/12/05
Subcarrier Allocation of Cognitive OFDM Systems with SWIPT-Enabled Relay 会议论文
International Conference on Communications, Signal Processing, and Systems, CSPS 2018, Dalian, China, 2018-07-14
作者:  Lin, Yuanrong;  Lu, Weidang;  Ye, Qibin;  Peng, Hong;  Zhan, Yu
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/02
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：34/0  |  提交时间：2019/12/05
Optimal placement of power quality monitors in complex distribution network based on topological degradation 会议论文
作者:  Yu, Junwei;  Sun, Yulian;  Lu, Jue;  Zou, Qiwu;  Xie, Xinlin
收藏  |  浏览/下载：23/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：36/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace